MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 144 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 2.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $110,000 | -41.2% | 89,020 | +46.5% | 0.00% | -40.0% |
| Q1 2017 | $187,000 | +70.0% | 60,785 | +125.6% | 0.01% | +66.7% |
| Q4 2016 | $110,000 | -71.6% | 26,938 | -62.5% | 0.00% | -62.5% |
| Q2 2016 | $388,000 | +58.4% | 71,925 | +145.5% | 0.01% | +14.3% |
| Q1 2016 | $245,000 | -11.6% | 29,296 | +30.6% | 0.01% | +40.0% |
| Q2 2015 | $277,000 | +74.2% | 22,433 | +59.6% | 0.01% | +66.7% |
| Q4 2014 | $159,000 | +101.3% | 14,053 | -9.9% | 0.00% | +200.0% |
| Q1 2014 | $79,000 | +12.9% | 15,603 | -15.1% | 0.00% | 0.0% |
| Q3 2013 | $70,000 | – | 18,387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
| Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
| Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
| INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
| GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
| Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
| Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |